When doing business, we continually find ourselves on the horns of dilemmas. Whether it is how to ensure equal access to health or how to approach stem cell research, we do not claim to have all the right answers. Over the years, our systematic stakeholder engagement approach has helped us address the difficult issues we face as a pharmaceutical company.
We are pleased to present three interactive challenges, which represent the topics: business ethics, climate change and economics & health. We encourage you to face the challenges and try the games in practice.
The Business Ethics Challenge
Doing business globally entails many challenges, not least when working in diverse cultures where appropriate business conduct can vary greatly. The pressures of a competitive business environment make it difficult, but even more important, to make the right choices in the market place.
How would you deal with business ethics issues in a day-to-day business situation? Take the business ethics challenge and find out how you ensure a balance between sales targets and company reputation.
The EnviroMan (climate change)
In January 2006, Novo Nordisk converted concerns about climate change into concrete actions by signing an agreement with WWF, World Wide Fund for Nature, to become a member of the Climate Savers programme. Under this agreement, Novo Nordisk has committed to the ambitious target of reducing its CO2 emissions by 10% by 2014 compared to 2004 levels.
Addressing climate change requires companies to undertake a range of measures from energy efficiency to fuel switching. Identifying cost-effective options is not always easy. How do you strike the right balance between economy and environment? In this easy-to-play game we challenge you to find the right balance between fossil fuels and renewable energy.
The Convincer (economics & health)
Current projections show that more than 438 million people will be living with diabetes by 2030. If nothing is done to slow the pandemic this may have severe consequences for both society and the people affected by diabetes. Diabetes costs national economies billions in lost productivity and strains even the best healthcare systems. And, if people with diabetes do not get proper treatment and support, their ability to live a full and productive life is at risk.
But this is not inevitable. One way to address this challenge is to ensure adequate investment in diabetes treatment and prevention. Can you convince the Minister of Health to invest in the proper diabetes initiatives? If you do, you will not only succeed in bringing down healthcare budgets, but also ensure improved quality of life for people with diabetes.
Any information presented in the interactive challenges (characters, situations, claims and arguments) are fictional and may not be accurate.